Literature DB >> 26559521

Novel Predictors of Poor Retention Following a Down-Referral from a Hospital-Based Antiretroviral Therapy Program in South Africa.

Jonathan Colasanti1, Darius McDaniel2, Brent Johnson3, Carlos Del Rio1, Henry Sunpath4, Vincent C Marconi1.   

Abstract

Worldwide, HIV care is becoming increasingly decentralized. For patients in care at centralized facilities, this requires down-referral to local clinics for their HIV care. Information on the real-world experience and predictors of retention in care at the time of down-referral is lacking. We sought to evaluate the effect of patient-level factors on retention in care surrounding a period of down-referral to new clinics for patients with and without virologic failure (VF) on their first-line ART. We conducted a secondary analysis of a case-control study of people living with HIV attending the Sinikethemba (SKT) Clinic at McCord Hospital in Durban, South Africa. Cases (VF) and controls (no VF) responded to a questionnaire focused on individual-level factors. Subsequently, participants self-reported either changing service provider (retained in care), were unable to be reached, died or reported not attending a new provider visit (not retained in care). Multivariate logistic regression was conducted with factors associated with not being retained in care in a univariate analysis. In all, 458 patients were enrolled in the parent study (158 cases and 300 controls) with a median age of 38 years old and with 65% women. A total of 436 (95%) participants successfully established care at the down-referral clinic. In the multivariate analysis, not being pleased with the clinic (SKT), lower adherence scores, and shorter duration of ART predicted failure of down-referral. Down-referral was successful even for patients with VF. Individual-level factors could act as predictors for patients at increased risk for poor retention during the down-referral process to a local clinic.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26559521      PMCID: PMC4817593          DOI: 10.1089/AID.2015.0227

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  21 in total

1.  World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.

Authors:  Michael R Jordan; Diane E Bennett; Silvia Bertagnolio; Charles F Gilks; Donald Sutherland
Journal:  Antivir Ther       Date:  2008

2.  Second-line antiretroviral therapy: long-term outcomes in South Africa.

Authors:  Richard A Murphy; Henry Sunpath; Carmen Castilla; Shameez Ebrahim; Richard Court; Hoang Nguyen; Daniel Kuritzkes; Vincent C Marconi; Jean B Nachega
Journal:  J Acquir Immune Defic Syndr       Date:  2012-10-01       Impact factor: 3.731

3.  Early warning indicators for first-line virologic failure independent of adherence measures in a South African urban clinic.

Authors:  Vincent C Marconi; Baohua Wu; Jane Hampton; Claudia E Ordóñez; Brent A Johnson; Dinesh Singh; Sally John; Michelle Gordon; Anna Hare; Richard Murphy; Jean Nachega; Daniel R Kuritzkes; Carlos del Rio; Henry Sunpath
Journal:  AIDS Patient Care STDS       Date:  2013-12       Impact factor: 5.078

Review 4.  Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review.

Authors:  Matthew P Fox; Sydney Rosen
Journal:  Trop Med Int Health       Date:  2010-06       Impact factor: 2.622

5.  Gender-specific risk factors for virologic failure in KwaZulu-Natal: automobile ownership and financial insecurity.

Authors:  Anna Q Hare; Claudia E Ordóñez; Brent A Johnson; Carlos Del Rio; Rachel A Kearns; Baohua Wu; Jane Hampton; Peng Wu; Henry Sunpath; Vincent C Marconi
Journal:  AIDS Behav       Date:  2014-11

6.  PEPFAR in transition--implications for HIV care in South Africa.

Authors:  Ingrid T Katz; Ingrid V Bassett; Alexi A Wright
Journal:  N Engl J Med       Date:  2013-10-10       Impact factor: 91.245

7.  The impact and cost of the 2013 WHO recommendations on eligibility for antiretroviral therapy.

Authors:  John Stover; Chaitra Gopalappa; Mary Mahy; Meg C Doherty; Philippa J Easterbrook; Gundo Weiler; Peter D Ghys
Journal:  AIDS       Date:  2014-03       Impact factor: 4.177

8.  Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme.

Authors:  Tom H Boyles; Lynne S Wilkinson; Rory Leisegang; Gary Maartens
Journal:  PLoS One       Date:  2011-05-03       Impact factor: 3.240

9.  The Linkage Outcomes of a Large-scale, Rapid Transfer of HIV-infected Patients From Hospital-based to Community-based Clinics in South Africa.

Authors:  Christie Cloete; Susan Regan; Janet Giddy; Tessa Govender; Alison Erlwanger; Melanie R Gaynes; Kenneth A Freedberg; Jeffrey N Katz; Rochelle P Walensky; Elena Losina; Ingrid V Bassett
Journal:  Open Forum Infect Dis       Date:  2014-08-12       Impact factor: 3.835

10.  Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique.

Authors:  Claudia Palladino; Verónica Briz; José María Bellón; Inês Bártolo; Patrícia Carvalho; Ricardo Camacho; M Ángeles Muñoz-Fernández; Rui Bastos; Rolanda Manuel; José Casanovas; Nuno Taveira
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more
  2 in total

1.  Comparing effectiveness of first-line antiretroviral therapy between peri-urban and rural clinics in KwaZulu-Natal, South Africa.

Authors:  Jaysingh Brijkumar; Johnathan A Edwards; Brent A Johnson; Claudia Ordonez; Henry Sunpath; Mitch Lee; Mathew R Dudgeon; Lydia Rautman; Selvan Pillay; Pravi Moodley; Y V Sun; José Castillo-Mancilla; Jonathan Z Li; Daniel R Kuritzkes; Mohamed Y S Moosa; Vincent Charles Marconi
Journal:  HIV Med       Date:  2022-01-12       Impact factor: 3.094

2.  Migrant patients living with HIV/AIDS in Japan: Review of factors associated with high dropout rate in a leading medical institution in Japan.

Authors:  Mari Kinoshita; Shinichi Oka
Journal:  PLoS One       Date:  2018-10-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.